Sign inGet started

WITTE OWEN N.

Insider CIK 1700969 · KITE Director · ALLO Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ALLO Allogene Therapeutics, Inc A Award deriv2026-06-182026-06-2395,400— $095,400SEC↗
ALLO Allogene Therapeutics, Inc A Award deriv2025-06-182025-06-2395,400— $095,400SEC↗
ALLO Allogene Therapeutics, Inc A Award deriv2024-06-052024-06-07191,082— $0191,082SEC↗
ALLO Allogene Therapeutics, Inc A Award2023-06-132023-06-1574,561— $0292,832SEC↗
ALLO Allogene Therapeutics, Inc S Sale2022-08-122022-08-155,000$17.25 $86.3K218,271SEC↗
ALLO Allogene Therapeutics, Inc S Sale2022-08-122022-08-155,000$17.25 $86.3K218,271SEC↗
ALLO Allogene Therapeutics, Inc S Sale2022-08-112022-08-1510,000$16.50 $165.0K223,271SEC↗
ALLO Allogene Therapeutics, Inc S Sale2022-08-112022-08-1510,000$16.50 $165.0K223,271SEC↗
ALLO Allogene Therapeutics, Inc S Sale2022-06-222022-06-2310,000$11.76 $117.6K233,271SEC↗
ALLO Allogene Therapeutics, Inc A Award deriv2022-06-152022-06-1735,535— $035,535SEC↗
ALLO Allogene Therapeutics, Inc A Award2022-06-152022-06-1722,089— $0243,271SEC↗
ALLO Allogene Therapeutics, Inc S Sale2021-09-092021-09-095,000$25.54 $127.7K221,182SEC↗
ALLO Allogene Therapeutics, Inc S Sale2021-08-202021-08-235,000$23.70 $118.5K231,182SEC↗
ALLO Allogene Therapeutics, Inc S Sale2021-08-202021-08-235,000$23.24 $116.2K226,182SEC↗
ALLO Allogene Therapeutics, Inc A Award deriv2021-06-102021-06-1128,015— $028,015SEC↗
ALLO Allogene Therapeutics, Inc S Sale2021-06-092021-06-119,969$25.05 $249.7K236,182SEC↗
ALLO Allogene Therapeutics, Inc A Award2020-06-052020-06-099,969— $0246,151SEC↗
ALLO Allogene Therapeutics, Inc A Award deriv2019-06-062019-06-2426,025— $026,025SEC↗
ALLO Allogene Therapeutics, Inc C Conversion deriv2018-10-152018-10-177,130— $00SEC↗
ALLO Allogene Therapeutics, Inc C Conversion2018-10-152018-10-1737,432— $0236,182SEC↗
ALLO Allogene Therapeutics, Inc P Buy2018-10-152018-10-1715,000$18.00 $270.0K198,750SEC↗
KITE Kite Pharma, Inc. D To issuer deriv2017-10-032017-10-058,810$88.79 $782.2K0SEC↗
KITE Kite Pharma, Inc. D To issuer deriv2017-10-032017-10-0510,000$173.11 $1.73M0SEC↗
KITE Kite Pharma, Inc. D To issuer deriv2017-10-032017-10-0530,000$124.91 $3.75M0SEC↗
KITE Kite Pharma, Inc. D To issuer deriv2017-10-032017-10-0517,130$96.11 $1.65M0SEC↗
KITE Kite Pharma, Inc. U Tender2017-10-032017-10-0558,535$180.00 $10.54M5,715SEC↗
KITE Kite Pharma, Inc. D To issuer2017-10-032017-10-055,715— $00SEC↗
KITE Kite Pharma, Inc. G Gift2017-09-182017-10-0512,000— $064,250SEC↗
KITE Kite Pharma, Inc. S Sale2017-06-262017-06-2612,500$100.60 $1.26M76,250SEC↗
KITE Kite Pharma, Inc. M Exercise deriv2017-06-232017-06-2610,000— $010,000SEC↗
KITE Kite Pharma, Inc. M Exercise deriv2017-06-232017-06-262,500— $00SEC↗
KITE Kite Pharma, Inc. M Exercise2017-06-232017-06-2610,000$6.89 $68.9K98,750SEC↗
KITE Kite Pharma, Inc. M Exercise2017-06-232017-06-262,500$62.44 $156.1K101,250SEC↗
KITE Kite Pharma, Inc. S Sale2017-06-232017-06-2612,500$100.00 $1.25M88,750SEC↗
KITE Kite Pharma, Inc. A Award deriv2017-06-202017-06-228,810— $08,810SEC↗
KITE Kite Pharma, Inc. A Award2017-06-202017-06-222,410— $088,750SEC↗
KITE Kite Pharma, Inc. A Award deriv2017-03-142017-03-1617,130— $017,130SEC↗
KITE Kite Pharma, Inc. A Award2017-03-142017-03-164,690— $086,340SEC↗